Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib
暂无分享,去创建一个
R. Jain | D. Fukumura | T. Padera | S. Liao | A. Kuo | K. Kozak | T. Hoshida | Jennifer Lobo | Angera H. Kuo